PharmaBoardroom

Interview with Gary Hendler, President & Chief Executive…

As the head of Eisai’s European operations, how would you assess the relevance of the European market for Eisai’s global operations when compared…

Interview with Ana Govedarica, General Manager, Roche Serbia

Roche is one of the oldest multinational pharmaceutical companies here in Serbia. How do you think your history in the country gives you an advantage…

Interview with Daniel Boda, President, National Agency for…

Under various former names for over five decades, the Agency has undoubtedly played a key role in setting a regulatory framework for Romania’s…

Interview with Peter Tsai, President, Orient Europharma Co.

You founded Orient Europharma in 1982, nearly 30 years ago. As you approach the 30 year mark, how has the company evolved to the way it is today, and…

Interview with Bednarz Bartosz, General Manager, AstraZeneca…

You have been quite recently appointed at the head of the Polish affiliate of AstraZeneca. With which personal ambitions did you come and what was the…

Interview with Odnir Finotti, Executive President, Pró…

When we last interviewed you in 2007, you said, “The generics business is a very exciting one,” but you “regret[ted] that the Government is not…

Interview with Nilton Paletta, President, Latin America, IMS…

We know the raw data already in the Brazilian market and the number changes since our last visit in 2007 – but how would you interpret these…

Interview with Michael Sean Reilly, General Manager for…

Michael Sean Reilly: General Manager for Pharmaceuticals Juan Carlos Berbessi: Medical Director Maria del Pilar Rubio: Medical Manager for Vaccines…

Interview with Andreas Fibig, CEO, Bayer Schering Pharma

The 2006 acquisition of Schering by Bayer is a prime example of the way that big pharma is now approaching growth through acquisition in this…

Interview with Anna Gajec, General Manager, Cegedim Poland

Given Cegedim’s global reach and your 13 year experience of operating as a consultant to the Polish pharma industry, how would you describe the…

Interview with Cesar Rengifo, President, GSK Brazil

You’ve made some bold moves in your career – from the head of vaccines in Latin America, followed by stints in Colombia, Puerto Rico, and…

Interview with Rolf E. Hoenger, General Manager, Productos Roche…

What has been the evolution of Roche’s operations in Colombia’s over the course of its proud 52-year history here? As with almost all…

Tagged with